A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
NCT ID: NCT01591044
Last Updated: 2016-09-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
301 participants
INTERVENTIONAL
2012-07-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
NCT01508936
A 12-Week Study in Adult Subjects With Asthma
NCT01516086
AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
NCT01018550
Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
NCT05935332
A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
NCT00983658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
R940343 2mg, 2 puffs bid
R343 2mg, 2 puffs bid
R940343 2mg
R343 2mg, 2 puffs bid
Placebo
Placebo
1 puff bid or 2 puffs bid
R940343 1mg, 1 puff bid
R343 1mg, 1 puff bid
R940343 1mg
R343 1mg, 1 puff bid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
1 puff bid or 2 puffs bid
R940343 1mg
R343 1mg, 1 puff bid
R940343 2mg
R343 2mg, 2 puffs bid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to perform spirometry
Exclusion Criteria
* Upper or lower respiratory infection
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigel Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elliott Grossbard, MD
Role: STUDY_DIRECTOR
Rigel Pharmaceuticals,Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
California Research Medical Group, Inc
Fullerton, California, United States
Allergy Medical Clinic Research Division
Los Angeles, California, United States
California Allergy & Asthma Medical Group, INC
Los Angeles, California, United States
Southern California Institute for Respiratory Diseases, Inc.
Los Angeles, California, United States
Allergy & Asthma Associates of Southern California
Mission Viejo, California, United States
CHOC PSF, AMC, Division of Allergy, Asthma & Immunology
Orange, California, United States
Peninsula Research Associates
Rolling Hills Estates, California, United States
Allergy Associates Medical Group. Inc.
San Diego, California, United States
Allergy & Asthma Med Group/Research Center
San Diego, California, United States
Allergy & Asthma Associates of Santa Clara Valley
San Jose, California, United States
Bensch Research Associates
Stockton, California, United States
Colorado Allergy and Asthma Clinic, PC
Centennial, Colorado, United States
Asthma & Allergy Associates, PC
Colorado Springs, Colorado, United States
National Jewish Health
Denver, Colorado, United States
Colorado Allergy & Asthma Centers, PC
Denver, Colorado, United States
Florida Center for Allergy & Asthma Research
Aventura, Florida, United States
Accelovance
Melbourne, Florida, United States
Sarasota Clinical Research
Sarasota, Florida, United States
Georgia Pollens Clinical Research Centers, Inc.
Albany, Georgia, United States
Idaho Allergy DBA Idaho Research
Eagle, Idaho, United States
Sneeze, Wheeze & Itch Associates
Normal, Illinois, United States
Chesapeake Clinical Research, Inc.
Baltimore, Maryland, United States
Northeast Medical Research Associates, Inc.
North Dartmouth, Massachusetts, United States
Respiratory Medicine Researh Institute of Michigan
Ypsilanti, Michigan, United States
Clinical Research Institute
Minneapolis, Minnesota, United States
Clinical Research Institute, Inc.
Plymouth, Minnesota, United States
Clinical Research of The Ozarks, Inc.
Columbia, Missouri, United States
The Clinical Research Center, LLC
St Louis, Missouri, United States
Clinical Research Group of Montana PLLC
Bozeman, Montana, United States
The Asthma & Allergy Center
Bellevue, Nebraska, United States
Atlantic Research Center, LLC
Ocean City, New Jersey, United States
Princeton Center for Clinical Research
Skillman, New Jersey, United States
Allergy Consultants, PA
Verona, New Jersey, United States
New York Pulmonary Associates, P.C.
New York, New York, United States
Allergy Asthma Immunology of Rochester (AAIR)
Rochester, New York, United States
Peters Medical Research
High Point, North Carolina, United States
North Carolina Clinical Research
Raleigh, North Carolina, United States
New Horizons Clinical Research
Cincinnati, Ohio, United States
Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma, United States
Allergy & Asthma Research Group
Eugene, Oregon, United States
Clinical Research Inst. of Southern Oregon, PC
Medford, Oregon, United States
Allergy Associates Research Center
Portland, Oregon, United States
Allergy & Clinical Immunology Associates
Pittsburgh, Pennsylvania, United States
National Allergy, Asthma and Uticaria Center of Charleston
Charleston, South Carolina, United States
Pharmaceutical Research & Consulting, Inc.
Dallas, Texas, United States
Western Sky Medical Research, Inc.
El Paso, Texas, United States
Live Oak Allergy & Asthma Clinic
Live Oak, Texas, United States
Allergy & Asthma Care of Waco, PA
Waco, Texas, United States
Allergy Asthma Research Institute
Waco, Texas, United States
ASTHMA, Inc.
Seattle, Washington, United States
MultiCare Pulmonary Specialists
Tacoma, Washington, United States
Joseph Greenbaum, MD
Hamilton, Ontario, Canada
Cheema Research, Inc.
Missassauga, Ontario, Canada
Niagara Clinical Research
Niagara Falls, Ontario, Canada
Ottawa Allergy Research Corp
Ottawa, Ontario, Canada
Pulmonary Care Clinic
Toronto, Ontario, Canada
Primary Care Lung Clinic
Toronto, Ontario, Canada
Dynamik Research, Inc.
Pointe-Claire, Quebec, Canada
Centre De recherche Appliquee en Allergie DeQuebec
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-940343-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.